AOS vs IKT · P/E 19, rev $1.00B vs $215.2M cap
Smith AO Corporation (AOS) versus Inhibikase Therapeutics Inc (IKT) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
Inhibikase Therapeutics Inc (IKT) is a biotechnology company listed on US.
Latest reported AOS revenue for 2026-06-30 was $1.00B. Net income was $124.9M. Revenue was up 6.2% from 2026-03-31 to 2026-06-30. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported IKT revenue for 2026-06-30 was $0. Net income was -$36.0M. IKT currently screens at market cap $215.2M.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. IKT currently screens at market cap $215.2M.
Not investment advice. Open the AOS and IKT stock pages for the full models.
Not investment advice.